About: diabetic cardiomyopathy

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: diabetic cardiomyopathy Goto Sponge Distinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

diabetes complication resulting in cardiac dysfunctions

Attributes	Values
rdf:type	Item
owl:sameAs	diabetic cardiomyopathy
description	zaplet sladkorne bolezni, ki povzroči motnje v delovanju srca (sl) diabetes complication resulting in cardiac dysfunctions (en)
health specialty	wds:Q5270132-865550C1-E878-44A2-8270-C90A89158E69 wds:Q5270132-AD481BAA-D79B-40CE-861B-BC2E46F948FB
health specialty	endocrinology cardiology
rdfs:label	cardiomyopathie diabétique (fr) diabetic cardiomyopathy (en) diabetična kardiomiopatija (sl) اعتلال عضلة القلب السكري (ar)
skos:prefLabel	cardiomyopathie diabétique (fr) diabetic cardiomyopathy (en) diabetična kardiomiopatija (sl) اعتلال عضلة القلب السكري (ar)
name	cardiomyopathie diabétique (fr) diabetic cardiomyopathy (en) diabetična kardiomiopatija (sl) اعتلال عضلة القلب السكري (ar)
subclass of	wds:Q5270132-239334d8-4973-28aa-e12a-dfe4e291fded wds:Q5270132-7ee7f5b6-4d95-29fc-99d2-ef371b1e2f00
subclass of	complications of diabetes mellitus extrinsic cardiomyopathy
skos:altLabel	Diabetic Cardiomyopathies (en) Diabetic cardiomyopathy (en)
OpenAlex ID	wds:Q5270132-DBA0662B-8FFF-4354-A7F4-74F1AE0E1BA3
UMLS CUI	wds:Q5270132-cdd6e670-46c6-2efb-870e-4b8f1a0db82b
MeSH descriptor ID	wds:Q5270132-426a509d-4040-d8fd-0964-fca3ae095151
Microsoft Academic ID	wds:Q5270132-37F600A6-9D81-4491-9141-75B2293F30A8
MeSH tree code	wds:Q5270132-0DEE81CF-DE5C-4506-B4DC-EC70F16AAAEC wds:Q5270132-C0445213-EEC9-42BF-A895-F296FB0AB665
ICD-11 ID (MMS)	wds:Q5270132-18cbbed6-592a-4024-bedd-5ed63ea0237c
ICD-11 (foundation)	wds:Q5270132-24BCF3D5-FC56-48E5-B3AE-2B4D59101E00
MeSH descriptor ID	http://id.nlm.nih.gov/mesh/D058065
Microsoft Academic ID	https://makg.org/entity/2776553924
MeSH tree code	http://id.nlm.nih.gov/mesh/C14.280.238.235 http://id.nlm.nih.gov/mesh/C19.246.099.625
OpenAlex ID	C2776553924
UMLS CUI	C0853897
MeSH descriptor ID	D058065
Microsoft Academic ID	2776553924
MeSH tree code	C14.280.238.235 C19.246.099.625
ICD-11 ID (MMS)	BC43.7
ICD-11 (foundation)	848543944
is owl:sameAs of	diabetic cardiomyopathy
is about of	diabetic cardiomyopathy https://www.wikidata.org/wiki/Special:EntityData/Q5270132 Diabetic cardiomyopathy https://ar.wikipedia.org/wiki/%D8%A7%D8%B9%D8%AA%D9%84%D8%A7%D9%84_%D8%B9%D8%B6%D9%84%D8%A9_%D8%A7%D9%84%D9%82%D9%84%D8%A8_%D8%A7%D9%84%D8%B3%D9%83%D8%B1%D9%8A
is main subject of	Defective sarcoplasmic reticular calcium transport in diabetic cardiomyopathy Diabetic cardiomyopathy: Pathophysiology, diagnostic evaluation and management Mitochondrial fatty acid oxidation alterations in heart failure, ischaemic heart disease and diabetic cardiomyopathy Diabetic cardiomyopathy and anesthesia: bench to bedside Exogenous hydrogen sulphide ameliorates diabetic cardiomyopathy in rats by reversing disordered calcium-handling system in sarcoplasmic reticulum Cannabinoid 1 receptor promotes cardiac dysfunction, oxidative stress, inflammation, and fibrosis in diabetic cardiomyopathy Diabetic cardiomyopathy and its mechanisms: Role of oxidative stress and damage Prevention of cardiac fibrosis and left ventricular dysfunction in diabetic cardiomyopathy in rats by transgenic expression of the human tissue kallikrein gene Myosin light-chain phosphorylation in diabetic cardiomyopathy in rats Insulin resistance and hyperinsulinaemia in diabetic cardiomyopathy Intravenous gene therapy with PIM-1 via a cardiotropic viral vector halts the progression of diabetic cardiomyopathy through promotion of prosurvival signaling Resveratrol, an activator of SIRT1, upregulates sarcoplasmic calcium ATPase and improves cardiac function in diabetic cardiomyopathy Diabetic cardiomyopathy: from the pathophysiology of the cardiac myocytes to current diagnosis and management strategies Disease modeling and phenotypic drug screening for diabetic cardiomyopathy using human induced pluripotent stem cells. Diabetic cardiomyopathy: evidence, mechanisms, and therapeutic implications Diabetic cardiomyopathy and metabolic remodeling of the heart Diabetic cardiomyopathy revisited Diabetic Cardiomyopathy: Mechanisms and Therapeutic Targets Diabetic cardiomyopathy: understanding the molecular and cellular basis to progress in diagnosis and treatment. Diabetic cardiomyopathy: myth or reality? Diabetic cardiomyopathy: mechanisms and new treatment strategies targeting antioxidant signaling pathways Cell-based therapies for diabetic complications Protective effect of total aralosides of Aralia elata (Miq) Seem (TASAES) against diabetic cardiomyopathy in rats during the early stage, and possible mechanisms Protein O-glycosylation induces collagen expression and contributes to diabetic cardiomyopathy in rat cardiac fibroblasts Chronic erythropoietin treatment affects different molecular pathways of diabetic cardiomyopathy in mouse. Diabetic cardiomyopathy: pathophysiology and clinical features Progressive attenuation of myocardial vascular endothelial growth factor expression is a seminal event in diabetic cardiomyopathy: restoration of microvascular homeostasis and recovery of cardiac function in diabetic cardiomyopathy after replenishme Subclinical Detection of Diabetic Cardiomyopathy with MicroRNAs: Challenges and Perspectives Diabetic cardiomyopathy, causes and effects MicroRNA-30d regulates cardiomyocyte pyroptosis by directly targeting foxo3a in diabetic cardiomyopathy Mice long-term high-fat diet feeding recapitulates human cardiovascular alterations: an animal model to study the early phases of diabetic cardiomyopathy Diabetic cardiomyopathy and diastolic heart failure -- difficulties with relaxation Diabetes and chronic heart failure: from diabetic cardiomyopathy to therapeutic approach. Rosuvastatin alleviates diabetic cardiomyopathy by inhibiting NLRP3 inflammasome and MAPK pathways in a type 2 diabetes rat model Mitochondrial dysfunction in diabetic cardiomyopathy Diabetic cardiomyopathy: signaling defects and therapeutic approaches Oxidative stress and diabetic cardiomyopathy: a brief review Diabetic cardiomyopathy: fact or fiction? Role of microRNAs in diabetes and its cardiovascular complications. Diabetic Cardiovascular Disease Induced by Oxidative Stress Potential role of nuclear factor κB in diabetic cardiomyopathy. Therapeutic targeting of oxidative stress with coenzyme Q10 counteracts exaggerated diabetic cardiomyopathy in a mouse model of diabetes with diminished PI3K(p110α) signaling. Probucol improves antioxidant activity and modulates development of diabetic cardiomyopathy Targeting the upregulation of reactive oxygen species subsequent to hyperglycemia prevents type 1 diabetic cardiomyopathy in mice Altered myocardial substrate metabolism is associated with myocardial dysfunction in early diabetic cardiomyopathy in rats: studies using positron emission tomography. Abnormal in vivo myocardial energy substrate uptake in diet-induced type 2 diabetic cardiomyopathy in rats Effect and mechanisms of zinc supplementation in protecting against diabetic cardiomyopathy in a rat model of type 2 diabetes Cardiac metallothionein induction plays the major role in the prevention of diabetic cardiomyopathy by zinc supplementation. Apelin gene therapy increases myocardial vascular density and ameliorates diabetic cardiomyopathy via upregulation of sirtuin 3.

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 196 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software